View in EDS HTML Full Text PDF Full Text

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.
Authors: Kumar S; Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu., Jagannath S; Mount Sinai Hospital, New York, NY, USA., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rosiñol L; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain., Leleu X; Centre Hospitalier Universitaire, Poitiers, France., Dimopoulos MA; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Korea University, Seoul, South Korea., Kastritis E; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Siegel DS; Hackensack University Medical Center, Hackensack, NJ, USA., Monge J; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Du J; Shanghai Changzheng Hospital, Shanghai, China., de la Rubia J; Hospital La Fe, Valencia, Spain., Asensi Cantó P; Hospital La Fe, Valencia, Spain., Lee JH; Gachon University Gil Medical Center, Incheon, South Korea., Mateos MV; University Hospital of Salamanca, IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Puertas B; University Hospital of Salamanca, IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Gozzetti A; University of Siena, Siena, Italy., Dytfeld D; Karol Marcinkowski University of Medical Sciences, Poznań, Poland., Ocio EM; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Blade J; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain., Ozaki S; Tokushima Prefectural Central Hospital, Tokushima, Japan., Beksac M; Istinye University, Ankara, Turkey., Escalante F; Complejo Asistencial Universitario de León, IBIOLEON, León, Spain., Nagaraj M; Mayo Clinic, Rochester, MN, USA., Hassan R; Mayo Clinic, Rochester, MN, USA., Bonar N; EVERSANA, Burlington, ON, Canada., Spin P; EVERSANA, Burlington, ON, Canada., Shokoohi M; EVERSANA, Burlington, ON, Canada., Siddiqui M; EVERSANA, Burlington, ON, Canada., Wang D; EVERSANA, Burlington, ON, Canada., Hou K; EVERSANA, Burlington, ON, Canada., West MED; EVERSANA, Burlington, ON, Canada., Hampp C; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Green J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Humblet O; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Breskin A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Harnett J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Ge W; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Sobel RE; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Jalbert JJ; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Kroog GS; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Rodriguez Lorenc K; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Ma Q; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Durie BGM; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Source: Blood cancer journal [Blood Cancer J] 2026 Mar 25; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 25.
Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2044-5385
DOI:10.1038/s41408-026-01466-2